EE200000646A - Homogeneous pharmaceutical compositions containing abacavir, lamivudine and zidovudine - Google Patents
Homogeneous pharmaceutical compositions containing abacavir, lamivudine and zidovudineInfo
- Publication number
- EE200000646A EE200000646A EEP200000646A EEP200000646A EE200000646A EE 200000646 A EE200000646 A EE 200000646A EE P200000646 A EEP200000646 A EE P200000646A EE P200000646 A EEP200000646 A EE P200000646A EE 200000646 A EE200000646 A EE 200000646A
- Authority
- EE
- Estonia
- Prior art keywords
- lamivudine
- zidovudine
- pharmaceutical compositions
- compositions containing
- homogeneous pharmaceutical
- Prior art date
Links
- LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
- 229960004748 abacavir Drugs 0.000 title 1
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000646A true EE200000646A (en) | 2002-04-15 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000646A EE200000646A (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions containing abacavir, lamivudine and zidovudine |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999060988A2 (en) * | 1998-05-29 | 1999-12-02 | University Of Florida | Combination therapy for treatment of fiv infection |
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| WO2003090762A1 (en) * | 2002-04-23 | 2003-11-06 | Lupin Limited | Long acting compositions comprising zidovudine and lamivudine |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| US20070059360A1 (en) * | 2005-07-29 | 2007-03-15 | Ashish Jaiswal | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| WO2009045975A1 (en) * | 2007-10-02 | 2009-04-09 | Rfs Pharma, Llc | Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| GB2470494B (en) * | 2008-01-17 | 2012-08-08 | Univ Holy Ghost Duquesne | Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS |
| KR101830715B1 (en) | 2010-01-27 | 2018-04-04 | 비이브 헬쓰케어 컴퍼니 | Combination for treating hiv infection |
| EP2579892A2 (en) | 2010-06-09 | 2013-04-17 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment |
| RU2014140177A (en) | 2012-03-05 | 2016-04-27 | Сипла Лимитед | PHARMACEUTICAL ANTIRETROVIRAL COMPOSITIONS |
| BR112015006558A2 (en) | 2012-10-23 | 2017-07-04 | Cipla Ltd | pharmaceutical composition, process for preparing a pharmaceutical composition, use of a pharmaceutical composition, and method for preventing or treating retrovirus diseases |
| CA3151685A1 (en) * | 2013-06-13 | 2014-12-18 | Akebia Therapeutics, Inc. | Compositions and methods for treating anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Application Discontinuation
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Withdrawn
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005418D0 (en) | 2000-10-27 |
| ZA200005922B (en) | 2001-10-23 |
| KR20010043128A (en) | 2001-05-25 |
| BR9910071A (en) | 2000-12-26 |
| NZ507745A (en) | 2004-07-30 |
| PL343710A1 (en) | 2001-08-27 |
| IL139181A0 (en) | 2001-11-25 |
| CA2330391A1 (en) | 1999-11-04 |
| IS5675A (en) | 2000-10-20 |
| HRP20000732A2 (en) | 2001-02-28 |
| GB9809213D0 (en) | 1998-07-01 |
| AP2000001971A0 (en) | 2000-12-31 |
| HUP0101622A3 (en) | 2003-09-29 |
| CN1411380A (en) | 2003-04-16 |
| HUP0101622A2 (en) | 2002-03-28 |
| TR200003157T2 (en) | 2001-01-22 |
| ID26955A (en) | 2001-02-22 |
| WO1999055372A1 (en) | 1999-11-04 |
| EA200000997A1 (en) | 2001-06-25 |
| NO20005418L (en) | 2000-11-29 |
| EP1083932A1 (en) | 2001-03-21 |
| SK16212000A3 (en) | 2001-07-10 |
| AU4135599A (en) | 1999-11-16 |
| JP2002512979A (en) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69924999D1 (en) | LIPASEHEMMER CONTAINING PHARMACEUTICAL COMPOSITIONS | |
| NO20002359L (en) | Adenosine derivatives and pharmaceutical composition containing the derivatives | |
| EE200000646A (en) | Homogeneous pharmaceutical compositions containing abacavir, lamivudine and zidovudine | |
| NO20005913D0 (en) | Medicinal Composition | |
| ID26982A (en) | TOPIRAMAT PHARMACEUTICAL COMPOSITION | |
| EE200000759A (en) | Pharmaceutical compositions for aerosols with two or more active ingredients | |
| BR9913138B1 (en) | QUINOLIN-2-ONA DERIVATIVE REPLACED WITH ALKINYL AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | |
| DE69726015D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING KOENZYM Q-10 | |
| ATE228357T1 (en) | NUCLEOTIDE ANALOGUE COMPOSITION | |
| ID22891A (en) | PHARMACEUTICAL COMPOSITION FOR PIPERIDINOALANOL-DECONGESTANT COMBINATIONS | |
| DK0920302T3 (en) | Pharmaceutical Aerosol Composition | |
| DE69900561D1 (en) | Pharmaceutical compositions containing mupirocin | |
| ID17774A (en) | ANTITROMBOSIS PHARMACY COMPOSITION | |
| DE59801987D1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING PEPTICHEMIO | |
| EE9900175A (en) | Pharmaceutical compositions containing lamivudine and zidovudine | |
| ID29294A (en) | PHARMACEUTICAL COMPOSITION | |
| IT1298731B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPLEX INCLUSION WITH MELATONIN | |
| ID25857A (en) | PHARMACEUTICAL COMPOSITION | |
| ID26215A (en) | PHARMACEUTICAL COMPOSITION | |
| ID26485A (en) | PAROXOXINE COMPOSITION | |
| ID23531A (en) | PHARMACEUTICAL COMPOSITION | |
| HK1034188A (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| SE9800052D0 (en) | Pharmaceutical compositions | |
| SE9800330D0 (en) | Pharmaceutical compositions | |
| BR1100755A (en) | pharmaceutical composition |